MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1200/jco.2010.33.4136

Медицинская библиотека · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2011

Features predicting sentinel lymph node positivity in Merkel cell carcinoma.

Schwartz Jennifer L, Griffith Kent A, Lowe Lori, Wong Sandra L, McLean Scott A, Fullen Douglas R, Lao Christopher D, Hayman James A, Bradford Carol R, Rees Riley S, Johnson Timothy M, Bichakjian Christopher K

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: Merkel cell carcinoma (MCC) is a relatively rare, potentially aggressive cutaneous malignancy. We examined the clinical and histologic features of primary MCC that may correlate with the probability of a positive sentinel lymph node (SLN).

METHODS

Ninety-five patients with MCC who underwent SLN biopsy at the University of Michigan were identified. SLN biopsy was performed on 97 primary tumors, and an SLN was identified in 93 instances. These were reviewed for clinical and histologic features and associated SLN positivity. Univariate associations between these characteristics and a positive SLN were tested for by using either the χ(2) or the Fisher's exact test. A backward elimination algorithm was used to help create a best multiple variable model to explain a positive SLN.

RESULTS

SLN positivity was significantly associated with the clinical size of the lesion, greatest horizontal histologic dimension, tumor thickness, mitotic rate, and histologic growth pattern. Two competing multivariate models were generated to predict a positive SLN. The histologic growth pattern was present in both models and combined with either tumor thickness or mitotic rate.

CONCLUSION

Increasing clinical size, increasing tumor thickness, increasing mitotic rate, and infiltrative tumor growth pattern were significantly associated with a greater likelihood of a positive SLN. By using the growth pattern and tumor thickness model, no subgroup of patients was predicted to have a lower than 15% to 20% likelihood of a positive SLN. This suggests that all patients presenting with MCC without clinical evidence of regional lymph node disease should be considered for SLN biopsy.

Для цитирования: Schwartz Jennifer L, Griffith Kent A, Lowe Lori, Wong Sandra L, McLean Scott A, Fullen Douglas R, Lao Christopher D, Hayman James A, Bradford Carol R, Rees Riley S, Johnson Timothy M, Bichakjian Christopher K. Features predicting sentinel lymph node positivity in Merkel cell carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011. DOI: 10.1200/jco.2010.33.4136.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.